FDA Inspection
Hapila GmbHHapila GmbH – FDA Inspection, Feb 28, 2019
Record Details
This FDA Inspection record concerns Hapila GmbH, with an inspection on February 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c0d03300-9d9e-4ef8-bf3f-9ac0f48ae5ae
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1086815
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hapila GmbH
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 6, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hapila GmbH
- FDA Inspection 1289300 - 2022-10-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.